Compounds > pyrazolanthrone
Page last updated: 2024-08-18

pyrazolanthrone and Cell Transformation, Neoplastic

pyrazolanthrone has been researched along with Cell Transformation, Neoplastic in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (27.27)29.6817
2010's8 (72.73)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kitanaka, C; Okada, M; Sato, A; Seino, M; Seino, S; Shibuya, K; Suzuki, S; Watanabe, E1
Kitanaka, C; Kurachi, H; Ohta, T; Okada, M; Seino, M; Seino, S; Shibuya, K; Suzuki, S1
Cormier, F; Dondi, E; Gardano, L; Guittat, L; Katzav, S; Laurienté, V; Razanadrakoto, L; Varin-Blank, N1
Hu, KB; Jiang, LN; Jie, J; Ni, WH; Tai, GX; Wang, J; Xie, F; Yuan, HY; Zhai, XY; Zhang, NN1
An, S; Choi, KS; Hwang, SG; Kang, SG; Kim, MJ; Kim, RK; Lee, SJ; Lim, EJ; Park, MJ; Suh, Y; Yoon, CH1
Funakoshi-Tago, M; Kasahara, T; Mashino, T; Nagata, T; Nakamura, S; Tago, K; Tanaka, K; Tsukada, M1
Arciniega, M; Augustin, M; Baek, S; Bode, AM; Byun, S; Dong, Z; Heo, YS; Holak, TA; Huber, R; Jung, SK; Kang, NJ; Kim, BY; Lee, HJ; Lee, KW; Popowicz, GM; Song, NR1
Li, X; Liang, M; Liu, Q; Liu, T; Lu, X; Qin, X; Sheyhidin, I; Zheng, S1
Colburn, N; Fujii, M; Hou, DX; Kai, K; Li, JJ; Lin, S; Terahara, N; Wakamatsu, M; Young, MR1
Montesano, R1
Claret, FX; Drakos, E; Elenitoba-Johnson, KS; Leventaki, V; Lim, MS; Medeiros, LJ; Rassidakis, GZ1

Other Studies

11 other study(ies) available for pyrazolanthrone and Cell Transformation, Neoplastic

ArticleYear
Specific role of JNK in the maintenance of the tumor-initiating capacity of A549 human non-small cell lung cancer cells.
    Oncology reports, 2013, Volume: 30, Issue:4

    Topics: Animals; Anthracenes; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Heterografts; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase 9; Neoplasm Transplantation; RNA Interference; RNA, Small Interfering

2013
Requirement of JNK signaling for self-renewal and tumor-initiating capacity of ovarian cancer stem cells.
    Anticancer research, 2014, Volume: 34, Issue:9

    Topics: Animals; Anthracenes; Cell Line, Tumor; Cell Transformation, Neoplastic; Disease Models, Animal; Enzyme Activation; Female; Gene Knockdown Techniques; Heterografts; Humans; JNK Mitogen-Activated Protein Kinases; Mice; Neoplastic Stem Cells; Ovarian Neoplasms; Signal Transduction; Spheroids, Cellular; Tumor Burden; Tumor Cells, Cultured

2014
Mutation of Vav1 adaptor region reveals a new oncogenic activation.
    Oncotarget, 2015, Feb-10, Volume: 6, Issue:4

    Topics: Animals; Anthracenes; Aspartic Acid; beta Catenin; Blotting, Western; Cell Line, Tumor; Cell Transformation, Neoplastic; Fibroblasts; HEK293 Cells; Humans; MAP Kinase Kinase 4; Mice; Mice, Nude; Mutation; NIH 3T3 Cells; Phosphorylation; Protein Binding; Proto-Oncogene Mas; Proto-Oncogene Proteins c-vav; RNA Interference; Signal Transduction; src Homology Domains

2015
Targeting MUC1 and JNK by RNA interference and inhibitor inhibit the development of hepatocellular carcinoma.
    Cancer science, 2017, Volume: 108, Issue:3

    Topics: Animals; Anthracenes; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Humans; JNK Mitogen-Activated Protein Kinases; Liver Neoplasms; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, Nude; Mucin-1; RNA Interference; RNA, Small Interfering; Transforming Growth Factor beta

2017
c-Jun N-terminal kinase has a pivotal role in the maintenance of self-renewal and tumorigenicity in glioma stem-like cells.
    Oncogene, 2012, Nov-01, Volume: 31, Issue:44

    Topics: Anthracenes; Cell Line, Tumor; Cell Transformation, Neoplastic; Down-Regulation; Glioma; Humans; JNK Mitogen-Activated Protein Kinases; Neoplastic Stem Cells; Signal Transduction; Spheroids, Cellular; Tumor Cells, Cultured

2012
Fullerene derivative prevents cellular transformation induced by JAK2 V617F mutant through inhibiting c-Jun N-terminal kinase pathway.
    Cellular signalling, 2012, Volume: 24, Issue:11

    Topics: Amino Acid Substitution; Animals; Anthracenes; Apoptosis; Cell Line; Cell Transformation, Neoplastic; Fullerenes; Janus Kinase 2; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 4; MAP Kinase Kinase 7; MAP Kinase Kinase Kinase 5; MAP Kinase Kinase Kinases; Mice; Mice, Nude; Proto-Oncogene Proteins c-myc; RNA Interference; RNA, Small Interfering; Signal Transduction; Transcription Factor AP-1

2012
Structural and functional analysis of the natural JNK1 inhibitor quercetagetin.
    Journal of molecular biology, 2013, Jan-23, Volume: 425, Issue:2

    Topics: Adaptor Proteins, Signal Transducing; Adenosine Triphosphate; Animals; Anthracenes; Binding, Competitive; Cell Transformation, Neoplastic; Chromones; Crystallography, X-Ray; Flavones; Humans; Mice; Mice, Hairless; Mitogen-Activated Protein Kinase 8; Models, Molecular; Molecular Dynamics Simulation; NF-kappa B; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Conformation; Proto-Oncogene Proteins c-akt; Skin Neoplasms; Transcription Factor AP-1; Ultraviolet Rays

2013
Roles of phosphorylated JNK in esophageal squamous cell carcinomas of Kazakh ethnic.
    Molecular carcinogenesis, 2014, Volume: 53, Issue:7

    Topics: Anthracenes; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Gene Expression Regulation, Neoplastic; Humans; Kazakhstan; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase 9; Phosphorylation; RNA Interference; RNA, Small Interfering; Wound Healing

2014
Anthocyanidins inhibit activator protein 1 activity and cell transformation: structure-activity relationship and molecular mechanisms.
    Carcinogenesis, 2004, Volume: 25, Issue:1

    Topics: Animals; Anthocyanins; Anthracenes; Anticarcinogenic Agents; Butadienes; Cell Transformation, Neoplastic; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinases; Nitriles; Phosphorylation; Structure-Activity Relationship; Superoxide Dismutase; Tetradecanoylphorbol Acetate; Transcription Factor AP-1

2004
Bone morphogenetic protein-4 abrogates lumen formation by mammary epithelial cells and promotes invasive growth.
    Biochemical and biophysical research communications, 2007, Feb-16, Volume: 353, Issue:3

    Topics: Animals; Anthracenes; Bone Morphogenetic Protein 4; Bone Morphogenetic Proteins; Butadienes; Cell Transformation, Neoplastic; Cells, Cultured; Epithelial Cells; Female; Humans; Imidazoles; Mammary Glands, Animal; Mice; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Nitriles

2007
NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic large-cell lymphoma.
    Blood, 2007, Sep-01, Volume: 110, Issue:5

    Topics: Anthracenes; Cell Cycle; Cell Transformation, Neoplastic; Chromosomes, Human, Pair 2; Chromosomes, Human, Pair 5; Cyclin A; Cyclin D3; Cyclins; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Humans; Jurkat Cells; Lymphoma, Large B-Cell, Diffuse; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase 9; Oncogene Proteins, Fusion; p21-Activated Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Signal Transduction; Transcription Factor AP-1; Transcription, Genetic; Translocation, Genetic; Up-Regulation

2007